Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
2017 · Journal of Translational Medicine · 43 citations
https://doi.org/10.1186/s12967-016-1095-2
A
Anna Campanati
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
313
Papers
5.4K
Citations
41
h-index
138
i10-index
Anna Campanati is an academic researcher from Marche Polytechnic University. The author has contributed to research in topics: Psoriasis: Treatment and Pathogenesis & Dermatology and Skin Diseases & Autoimmune Bullous Skin Diseases. The author has an h-index of 41, co-authored 267 publications.
ORCID: 0000-0002-3740-0839Papers by this author
worksNicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma
2018 · Melanoma Research · 40 citations
https://doi.org/10.1097/cmr.0000000000000430
Paraoxonase‐2: A potential biomarker for skin cancer aggressiveness
2020 · European Journal of Clinical Investigation · 40 citations
https://doi.org/10.1111/eci.13452
Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis
2019 · Expert Opinion on Drug Metabolism & Toxicology · 36 citations
https://doi.org/10.1080/17425255.2019.1681969
IL-17, IL-23, and p73 expression in cutaneous melanoma
2015 · Melanoma Research · 27 citations
https://doi.org/10.1097/cmr.0000000000000151
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
2020 · Dermatology and Therapy · 27 citations
https://doi.org/10.1007/s13555-020-00379-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat